India’s Drug Makers Shudder as Trump Again Threatens Tariffsnews2025-04-09T09:01:48+00:00April 9th, 2025|The New York Times|
Trump Cut H.I.V. Funding. My Patients Are Scared.news2025-04-08T09:01:36+00:00April 8th, 2025|The New York Times|
Boston Faces Identity Crisis Amid Trump’s Cuts to University and Research Fundingnews2025-04-06T09:01:05+00:00April 6th, 2025|The New York Times|
Trump Rejects Proposal for Medicare to Cover Wegovy and Other Obesity Drugsnews2025-04-04T23:42:16+00:00April 4th, 2025|The New York Times|
Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticalsnews2025-04-04T09:00:28+00:00April 4th, 2025|The New York Times|
FDA Layoffs Could Raise Drug Costs and Erode Food Safetynews2025-04-04T01:59:02+00:00April 4th, 2025|The New York Times|
La derecha en EE. UU. sigue defendiendo a la ivermectinanews2025-04-01T14:33:37+00:00April 1st, 2025|The New York Times|
Why the Right Still Embraces Ivermectinnews2025-03-31T15:01:02+00:00March 31st, 2025|The New York Times|
Covid’s Deadliest Effect Took Five Years to Appearnews2025-03-10T09:01:46+00:00March 10th, 2025|The New York Times|
FDA Nominee Marty Makary to Face Grilling Over Cutbacks and Policy Shiftsnews2025-03-06T10:02:40+00:00March 6th, 2025|The New York Times|